🔎 Trials Near Me

Utama › Hipertensi Arteri Pulmonari › Kansas

Kajian klinikal Hipertensi Arteri Pulmonari di Kansas

7 kajian untuk Hipertensi Arteri Pulmonari sedang mencari peserta di lokasi di Kansas.

Bandar di Kansas

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  • USA010, Kansas City
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07481981

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  • University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07365332

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • The University of Kansas Medical Center Research Institute, Kansas City
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07175038

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  • University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06274801

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  • U of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 21 Jul 2026 · NCT06649110

Pulmonary Hypertension Association Registry

  • KU Medical Center, Kansas City
Mengambil pesertaKajian pemerhatian
Umur 0 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT04071327

Pulmonary Hypertension Biorepository and Registry

  • University of Kansas Medical Center, Kansas City
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Ogo 2025 · NCT04808596

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.